Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Book Value per Share : ¥2.33 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Book Value per Share?

Hunan Er-Kang Pharmaceutical Co's book value per share for the quarter that ended in Mar. 2024 was ¥2.33.

During the past 12 months, Hunan Er-Kang Pharmaceutical Co's average Book Value Per Share Growth Rate was -4.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -5.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -3.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hunan Er-Kang Pharmaceutical Co was 78.20% per year. The lowest was -22.10% per year. And the median was 10.10% per year.

Hunan Er-Kang Pharmaceutical Co's current price is ¥2.61. Its book value per share for the quarter that ended in Mar. 2024 was ¥2.33. Hence, today's PB Ratio of Hunan Er-Kang Pharmaceutical Co is 1.12.

During the past 13 years, the highest P/B Ratio of Hunan Er-Kang Pharmaceutical Co was 23.84. The lowest was 1.00. And the median was 2.01.

Hunan Er-Kang Pharmaceutical Co Book Value per Share Historical Data

The historical data trend for Hunan Er-Kang Pharmaceutical Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Er-Kang Pharmaceutical Co Book Value per Share Chart

Hunan Er-Kang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Book Value per Share

Get a 7-Day Free Trial

2.82

2.35

2.45

2.35

Hunan Er-Kang Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Book Value per Share	Get a 7-Day Free Trial															2.45	2.48	2.46	2.35	2.33

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hunan Er-Kang Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's PB Ratio falls into.

Hunan Er-Kang Pharmaceutical Co Book Value per Share Calculation

Hunan Er-Kang Pharmaceutical Co's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4,836	-	0)	/	2,063
	=	2.34

Hunan Er-Kang Pharmaceutical Co's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4,805	-	0)	/	2,063
	=	2.33

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Hunan Er-Kang Pharmaceutical Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Book Value per Share

Traded in Other Exchanges

N/A

Address

Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331

Website

http://www.hnerkang.com

Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Headlines

No Headlines